XPH
State Street SPDR S&P Pharmaceuticals ETF
📎 Investment Objective
The SPDR S&P Pharmaceuticals ETF (XPH) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
Overview
ETF tracking State Street SPDR S&P Pharmaceuticals ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The SPDR S&P Pharmaceuticals ETF (XPH) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
🎯 Investment Strategy
The fund employs a passive management strategy, investing in a representative sample of securities included in the underlying index to seek to track the performance of the index. The index includes companies from the pharmaceutical sub-industry.
✨ Key Features
- Provides exposure to the pharmaceutical industry
- Passively managed to track the S&P Pharmaceuticals Select Industry Index
- Low expense ratio of 0.00%
- Relatively small fund with $0 in assets under management
⚠️ Primary Risks
- Concentration risk as the fund is focused on a single industry
- Potential volatility due to the cyclical nature of the pharmaceutical sector
- Liquidity risk given the small asset size of the fund
- Tracking error risk as the fund may not perfectly replicate the index performance
👤 Best For
This ETF may be suitable for investors seeking broad exposure to the pharmaceutical industry as part of a diversified portfolio. It may be of particular interest to investors with a higher risk tolerance who believe in the long-term growth potential of the pharmaceutical sector.